New York City, NY -- (SBWIRE) -- 10/30/2013 -- StockMarketIntel.com issues a special report on the following stocks: North American Oil & Gas Corp (OTCBB:NAMG), Buka Ventures Inc (OTCBB:NNRX), Essilor International SA-ADR (OTCMKTS:ESLOY), Incyte Corporation (NASDAQ:INCY)
North American Oil & Gas Corp (OTCBB:NAMG) declined -7.94%, trading on 3.01 million shares, to end the trade at $1.16. The stock changed hands in a range of $1.07 to $1.30, bringing its market capitalization to about $69.98 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.25 and was moved to the maximum level of $1.67. North American Oil & Gas Corp. (NAMOG) is a development-stage company. The Company is engaged in oil and gas exploration in California, through its subsidiary Lani. The Company is focused on its oil and natural gas exploration, exploitation and development operations on projects located in the San Joaquin Basin, California; its Tejon Main prospect, Tejon Extension prospect, and White Wolf project. Lani drilled its exploratory well on the Tejon Ranch Extension on November 25, 2012.
Has NAMG Found The Bottom and Ready To Move Up? Find Out Here
Buka Ventures Inc (OTCBB:NNRX) declined -2.50%, to complete the trading session at $0.488, with a total volume of 328,998 shares. The stock, on average, trades on a volume of 1.67 million shares. It floated in a range of $0.48 to $0.50. Its market capitalization now moved to about $23.25 million. In the past 52 weeks, the share price has not declined below $0.12 and above $1.48.
Has NNRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Essilor International SA-ADR (OTCMKTS:ESLOY) recorded a gain of 0.73% and was in a range of $53.92-$54.03 before closing at $54.03. The stock completed the day with a total volume of 9,476 shares, versus an average volume of 44,591 shares. The share price hit its 52-week low of $44.55 and $59.27 was the best price. Essilor International SA is a France-based ophthalmic optics company. The Company is engaged in the corrective lenses. Its brands are Varilux, Crizal, Definity, Xperio, Optifog, Kodak and Foster Grant. The Company also develops and sells equipment for prescription laboratories, particularly through its subsidiary Satisloh, as well as instruments and services designed for optical professionals.
Why Should Investors Buy ESLOY After The Recent Gain? Just Go Here and Find Out
Incyte Corporation (NASDAQ:INCY) added 3.07% yesterday, bringing its market capitalization around $6.22 billion. The total number of shares that changed hands during the session was 763,875 shares, as compared to average trading volume of 1.44 million shares. The share price, after opening at $39.81, made a high of $40.80 and hovered above $39.32 to end the day at $40.64. Incyte Corporation (Incyte) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs. Its advanced compound, JAKAFI (ruxolitinib), also known as INCB18424 and INC424, is an oral Janus associated kinase (JAK) inhibitor used for the treatment for patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
What was the Moving Force behind INCY on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)